The no. 1 platform for automated cell manufacturing
The no. 1 platform for automated cell manufacturing
For over 10 years, the CliniMACS Prodigy® Platform has transformed cell therapy manufacturing and today is the most trusted automated solution in hospitals and industry. Our platform simplifies the complexity of cell and gene therapy (CGT) production by integrating process steps into one closed workflow. With a wide range of applications, the configurable and scalable CliniMACS Prodigy Platform offers full flexibility for autologous and allogeneic CGT strategies.
We understand the challenges on the road to cell therapy manufacturing success and help you translate your manual protocols into tailored automated processes. Meet your specific goals and regulatory requirements, take advantage of the most widely used cell manufacturing platform on the market, and turn your CGT vision into reality.
For complete regulatory notes click here.
8 commercially approved cell therapies* built on the CliniMACS Prodigy Platform
More than 200 active clinical trials** worldwide, driving innovation
Over 400 customized applications on one versatile platform
*Approved substantially manipulated cell therapies and gene-modified cell therapies in Europe, USA, and India.
**Active clinical trials, hospital treatments, or commercial treatments using the CliniMACS Prodigy for the manufacturing of cell products.
The CliniMACS Prodigy® Platform
Request more information about the CliniMACS Prodigy and our clinical applications
Discover clinical applications for the CliniMACS Prodigy Platform
A wide variety of cell processing applications are available for the CliniMACS Platforms. If a standard process is not available to support your desired approach, then our Customized Application Service team can tailor a solution to fit your process.
33 products found
|